Tag: AbbVie Inc
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of th [...]
We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
Traders work on the floor of the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued their upward gains Thursday wit [...]
New stocks, 2 trades, earnings recap
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. L [...]
Multiple revenue misses in one of our winners convinced us to take profits and get out
We never like to sell on a down day. But after an iffy quarter, we decided to exit.
www.cnbc.com [...]
Still oversold, picking at chip stocks, Club names in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Friday's key moments. M [...]
Passage of Inflation Reduction Act gives Medicare historic new powers
A pharmacist collects medications for prescriptions at a pharmacy.Simon Dawson | Bloomberg | Getty ImagesMedicare is poised to renegotiate the prices [...]
AbbVie's mixed quarter doesn't warrant a 5% stock drop. Here's why
It wasn't a clean quarter from AbbVie but Friday's selloff is a bit confusing.
www.cnbc.com [...]
Tuesday's market bounce allows us to raise some cash to buy in the next downturn
We're raising cash about equal to what we put to work last Friday in three trades when the market was much lower.
www.cnbc.com [...]
Rapid7 is not a buy
Abbvie Inc: "I think the answer is that Abbvie, which we own big for our Charitable Trust, goes higher."NVIDIA Corp: "You have to buy it gingerly. Why [...]
Investing Club: We're trimming one of our big winners with the S&P 500 on a four-day win streak
We see now as a pretty good level in the overall market to start raising some cash.
www.cnbc.com [...]
I will only recommend stocks with actual earnings
Crispr Therapeutics: "They're estimated to lose a lot of money. But more importantly, this is the kind of company right now that is so out of favor th [...]
Have your buy list ready for ‘hideous moments’
CNBC's Jim Cramer on Friday previewed next week's major corporate earnings reports after Wall Street capped off a wild week filled with major intraday [...]
Don’t sell Canopy Growth at these low levels
Vista Outdoor: "That's actually one of the most inexpensive stocks in the entire market. Just so you know, they're actually featuring CamelBak right n [...]
Stocks making the biggest moves midday: Starbucks, Apple, Amazon, more
Starbucks coffee shop logo seen at one of their stores.Stephen Zenner | LightRocket | Getty ImagesCheck out the companies making headlines in midda [...]
‘We’re at a crucial level on this market’
CNBC's Jim Cramer on Wednesday delivered a message of warning to retail buyers who helped drive up the worth of so-called meme shares final week.Th [...]